Since the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was
reported in Wuhan, China, in December 2019, Coronavirus-19 (COVID-19) has become a …

Objective This study aimed to retrospectively analyze reported Guillain–Barré syndrome
(GBS) cases that occurred after COVID-19 vaccination. Methods Case reports of GBS …

We report a case of Guillain-Barré syndrome (GBS) following the first dose of
Oxford/AstraZeneca COVID-19 vaccine with papilledema as atypical onset. As the COVID …

There are now several reports on neurologic features of SARS-CoV-2 infection [1, 2]. In a
recent study of 214 patients with COVID-19, 78 (36.4%) patients had neurological …

Background Amidst growing concern about an increased risk of Guillain–Barré syndrome
(GBS) following COVID-19 vaccination, clinical and electrodiagnostic features have not …

Originating from Wuhan, China, COVID-19 has rapidly spread worldwide. Neurological
manifestations are more commonly associated with severe COVID-19 infection. Guillain …

Abstract Coronavirus disease 2019 (COVID‐19) has been shown to be associated with a lot
of neurological complications, of whom Guillain‐Barre syndrome (GBS) is an important post …

Guillain-Barré syndrome (GBS) is the most common and severe acute paralytic neuropathy,
with about 100,000 people developing the disorder every year worldwide [1]. Up to two …

Guillain-Barré Syndrome as a Neurological Complication of No... : The Neurologist Guillain-Barré
Syndrome as a Neurological Complication of Novel COVID-19 Infection: A Case Report and …

There is concern that the global burden of coronavirus disease of 2019 (COVID-19) due to
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection might yield an …